Multiarm trials with follow-up on participants are commonly implemented to assess treatment effects on a population over the course of the studies. Dropout is an unavoidable issue especially when the duration of the multiarm study is long. Its impact is often ignored at the design stage, which may lead to less accurate statistical conclusions. We develop an optimal design framework for trials with repeated measurements, which takes potential dropouts into account, and we provide designs for linear mixed models where the presence of dropouts is noninformative and dependent on design variables. Our framework is illustrated through redesigning a clinical trial on Alzheimer's disease, whereby the benefits of our designs compared with standard d...
Abstract: Many clinical trials enrol patients from different medical centres. Multi-centre studies a...
Optimal designs are a class of experimental designs that are efficient with respect to some statisti...
When a researcher desires to test several treatment arms against a control arm, a two-stage adaptive...
Multiarm trials with follow-up on participants are commonly implemented to assess treatment effects ...
Multiarm trials with follow-up on participants are commonly implemented to assess treatment effects ...
Multiarm trials with follow‐up on participants are commonly implemented to assess treatment effects ...
A cross-over study is a comparitive experiment in which subjects receive a sequence of two or more t...
With current success rates of confirmatory studies being only around 50%, new approaches to drug dev...
Multi-arm multi-stage trials can improve the efficiency of the drug development process when multipl...
Dropout is a common issue in randomized controlled clinical trials and can negatively impact the int...
The reduced efficiency of the cluster randomized trial design may be compensated by implementing a m...
When performing a repeated measures experiment, such as a clinical trial, there is a risk of subject...
Phase II clinical trials are a critical aspect of the drug development process. With drug developmen...
It is well known that the statistical power of randomized controlled trials with a continuous outcom...
In drug development, there is often uncertainty about the most promising among a set of different tr...
Abstract: Many clinical trials enrol patients from different medical centres. Multi-centre studies a...
Optimal designs are a class of experimental designs that are efficient with respect to some statisti...
When a researcher desires to test several treatment arms against a control arm, a two-stage adaptive...
Multiarm trials with follow-up on participants are commonly implemented to assess treatment effects ...
Multiarm trials with follow-up on participants are commonly implemented to assess treatment effects ...
Multiarm trials with follow‐up on participants are commonly implemented to assess treatment effects ...
A cross-over study is a comparitive experiment in which subjects receive a sequence of two or more t...
With current success rates of confirmatory studies being only around 50%, new approaches to drug dev...
Multi-arm multi-stage trials can improve the efficiency of the drug development process when multipl...
Dropout is a common issue in randomized controlled clinical trials and can negatively impact the int...
The reduced efficiency of the cluster randomized trial design may be compensated by implementing a m...
When performing a repeated measures experiment, such as a clinical trial, there is a risk of subject...
Phase II clinical trials are a critical aspect of the drug development process. With drug developmen...
It is well known that the statistical power of randomized controlled trials with a continuous outcom...
In drug development, there is often uncertainty about the most promising among a set of different tr...
Abstract: Many clinical trials enrol patients from different medical centres. Multi-centre studies a...
Optimal designs are a class of experimental designs that are efficient with respect to some statisti...
When a researcher desires to test several treatment arms against a control arm, a two-stage adaptive...